Ownership Submission
|
FORM 3
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
|
|
OMB APPROVAL
|
|
OMB Number:3235-0104Expires:January 31, 2005Estimated average burden hours per response...0.5
|
|
|
1. Name and Address of Reporting Person *
|
|
Pazdan Christopher
|
|
2. Date of Event Requiring Statement (Month/Day/Year)
2024-07-18
|
3. Issuer Name and Ticker or Trading Symbol
KORU Medical Systems, Inc. [KRMD]
|
|
(Last)
|
(First)
|
(Middle)
|
|
C/O KORU MEDICAL SYSTEMS, INC. , 100 CORPORATE DRIVE
|
|
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
|
_____ Director
|
_____ 10% Owner
|
|
_____ Officer (give title below)
|
_____ Other (specify below)
|
|
Chief Operating Officer /
|
|
5. If Amendment, Date Original Filed(Month/Day/Year)
|
|
|
6. Individual or Join/Group Filing(Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
|
|
|
Table I - Non-Derivative Securities Beneficially Owned
|
|
|
1.Title of Security
|
2. Amount of Securities Beneficially Owned
|
3. Ownership Form: Direct (D) or Indirect (I)
|
4. Nature of Indirect Beneficial Ownership
|
|
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
|
1. Title of Derivate Security
|
2. Date Exercisable and Expiration Date
|
3. Title and Amount of Securities Underlying Derivative Security
|
4. Conversion or Exercise Price of Derivative Security
|
5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
|
6. Nature of Indirect Beneficial Ownership
|
|
Date Exercisable
|
Expriation Date
|
Title
|
Amount or Number of Shares
|
Reporting Owners
|
Reporting Owner Name / Address
|
Relationships
|
|
Director
|
10% Owner
|
Officer
|
Other
|
Pazdan Christopher
C/O KORU MEDICAL SYSTEMS, INC.
100 CORPORATE DRIVE
MAHWAH, NJ07430
|
|
|
Chief Operating Officer
|
|
Signatures
|
/s/ Thomas Adams Attorney-In-Fact
|
2024-07-31
|
|
**Signature of Reporting Person
|
Date
|
Explanation of Responses:
|
(*)
|
If the form is filed by more than one reporting person, see Instruction 5(b)(v).
|
|
(**)
|
Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
|
|
(1)
|
Shares are subject to a 4 year vesting schedule. 25% of the Shares vest on the 1 year anniversary of the 09/15/2021 date of the grant (the "Vesting Commencement Date"), and the remaining Shares vest as follows: 25% of the Shares at the end of each successive 12 month period following the Vesting Commencement Date.
|
|
(2)
|
Shares are subject to a 4 year vesting schedule. 25% of the Shares vest on the 1 year anniversary of the 03/15/2024 date of the grant (the "Vesting Commencement Date"), and the remaining Shares vest as follows: 25% of the Shares at the end of each successive 12 month period following the Vesting Commencement Date.
|
|
(3)
|
Granted on 04/24/24. Vesting is dependent upon the achievement by KORU Medical Systems, Inc. of certain performance criteria. Thue number of performance share units scheduled to vest on December 31, 2024 will vary between 0% and 150% of the number reported, depending on whether and the extent to which the performance criteria are met. Performance share units are paid out in shares of KORU Medical Systems, Inc.'s common stock on a one-for-one basis.
|
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient,
See Instruction 6 for procedure.Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.
